CYCL OTC

Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal feed within the People's Republic of China. The company's product line includes various biological bacterium blends, notably those based on Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM). For crop cultivation, these AM/HM blends – exemplified by Bulgaria lactobacillus, beer microzyme, and dark red spirilla – are designed to boost beneficial microbial populations in soil, suppress harmful fungi and putrefactive bacteria, enhance nutrient absorption, and ultimately help mitigate diseases in crops and livestock. In the livestock sector, AM/HM-based feed additives serve to tenderize feed, inhibit the growth of pathogenic bacteria, and provide crucial nutrients such as organic acids, vitamins, enzymes, antibiotics, mycelium protein, and other growth stimulants, thereby ensuring a balanced nutritional intake. Furthermore, Cycclone offers FGW bacterial preservatives, utilized for preserving animal specimens in scientific research and extending the freshness of agricultural produce. It also supplies bacteria-based fertilizers for foliar application on fruits and vegetables. Beyond its biotechnology operations, the company holds investments in residential and commercial real estate. Founded in 2004 as China Dasheng Biotechnology Co., the company officially adopted the name Cycclone Inc. in May 2025 and is headquartered in Lanzhou, China.